Befovacimab Uses, Dosage, Side Effects and more
| Trade Name | Befovacimab |
| Generic | Anti-TFPI |
| Anti-TFPI Other Names | Befovacimab, Human tissue factor pathway inhibitor-neutralizing antibody (bay 1093884), Immunoglobulin g2, anti-(human tissue factor pathway inhibitor) (human monoclonal 1093884 .gamma.2-chain), disulfide with human monoclonal 1093884 .lambda.-chain, dimer |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
